40 results
6-K
EX-99.2
ENLV
Enlivex Therapeutics Ltd
11 Apr 24
Enlivex Announces Topline Results of Its Phase II Trial Evaluating Allocetra™ In Patients With Sepsis
8:13am
overactive immune response to infection that attacks the body and leads to: tissue damage, organ failure, death. Brain Lungs Liver Kidneys H eart 1 … 3 4 0 1 2 3 4 0 1 2 3 4 0 1 2 3 4 0 1 2 3 4 0 1 2 3 4 sepsis severe sepsis septic shock death 4 3 2 1 0 4 3 2 1 0 4 3 2 1 0 4 3 2 1 0 4 3 2 1 0
14
6-K
EX-99.3
ENLV
Enlivex Therapeutics Ltd
22 Aug 22
Condensed Consolidated Financial Statements
8:08am
monotherapy has shown response rates of only 7-15% in prior clinical trials in ovarian cancer, which is currently the fifth leading cause of cancer death
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
31 May 22
Report of Foreign Private Issuer
8:04am
, as ovarian cancer is currently the fifth leading cause of cancer death among women.
Murine ovarian cancer study results:
Substantial survival effect … is currently the fifth leading cause of cancer death among women. Stand-alone therapy with PD1 checkpoint inhibitors, which are designed to treat cancer
6-K
EX-1.1
gubym def7qw
12 Feb 21
Enlivex Announces Closing of Previously Announced Bought Deal Offering of Approximately $46.0 Million Ordinary Shares
5:17pm
6-K
EX-99.1
g8kwvj3y7ru9x34mru6k
21 Dec 20
Enlivex Announces Pre-Print Publication of Full Results from Phase Ib Severe Sepsis Trial on medRxiv
8:02am
6-K
EX-99.1
yw1lkf4 rb
18 Mar 20
Enlivex Announces Positive Final Safety and Efficacy Data From Clinical Trial of Off-The-Shelf Allocetra in Patients with Severe Sepsis
8:26am
424B5
x1alknoq
3 Mar 20
Prospectus supplement for primary offering
5:13pm
424B5
1g86rw0 iv
26 Feb 20
Prospectus supplement for primary offering
8:23am
20-F/A
l56tdlf
23 Jan 20
Annual report (foreign) (amended)
4:31pm
424B5
9n01w9y wmr1ffr1aw5
20 Nov 19
Prospectus supplement for primary offering
4:46pm
6-K
EX-99.1
m10n7
4 Nov 19
Enlivex Therapeutics Announces Positive Interim Safety and Efficacy Data From Ongoing Trial of Off-The-Shelf Allocetra in Patients with Severe Sepsis
7:30am
6-K
EX-99.1
305h bxwu6qsd
19 Aug 19
Report of Foreign Private Issuer
7:31am